Infectious Diseases Unit, Sheba Medical Center, Tel Hashomer, 52621, Israel.
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1811-7. doi: 10.1007/s10096-011-1506-5. Epub 2012 Jan 14.
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged during recent years in several intensive care units. The objective of our study was to determine the incidence of CRKP and the risk factors associated with acquisition during intensive care unit (ICU) stay. This prospective cohort study was conducted between May 2007 and April 2008 in a medical-surgical ICU at a tertiary medical center. Rectal surveillance cultures were obtained from patients on admission and twice weekly. Of screened patients, 7.0% (21/299) were CRKP colonized on admission to the ICU. One hundred eighty (81%) patients were screened at least twice. Of these, 48 (27%) patients acquired CRKP during ICU stay. Of the 69 CRKP colonized patients (both imported and ICU acquired), 29% (20/69) were first identified by microbiologic cultures, while screening cultures identified 49 patients (71%). Of these, 23 (47%) subsequently developed clinical microbiological cultures. Independent risk factors for CRKP acquisition included recent surgery (OR 7.74; CI 3.42-17.45) and SOFA score on admission (OR 1.17; CI 1-1.22). In conclusion, active surveillance cultures detected a sizable proportion of CRKP colonized patients that were not identified by clinical cultures. Recent surgical procedures and patient severity were independently associated with CRKP acquisition.
近年来,耐碳青霉烯类肺炎克雷伯菌(CRKP)在几家重症监护病房(ICU)中出现。本研究的目的是确定 ICU 住院期间 CRKP 的发生率和获得性感染的相关危险因素。这是一项前瞻性队列研究,于 2007 年 5 月至 2008 年 4 月在一家三级医疗中心的内科-外科 ICU 进行。对入院患者进行直肠监测培养,每周两次。在筛查的患者中,7.0%(21/299)在入住 ICU 时定植了耐碳青霉烯类肺炎克雷伯菌。180 例(81%)患者至少筛查了两次。其中,48 例(27%)患者在 ICU 期间获得了耐碳青霉烯类肺炎克雷伯菌。在 69 例耐碳青霉烯类肺炎克雷伯菌定植患者(包括输入性和 ICU 获得性)中,29%(20/69)首先通过微生物培养确定,而筛查培养确定了 49 例(71%)。其中,23 例(47%)随后出现了临床微生物学培养阳性。CRKP 获得的独立危险因素包括近期手术(OR7.74;95%CI3.42-17.45)和入院时 SOFA 评分(OR1.17;95%CI1-1.22)。总之,主动监测培养发现了相当一部分未通过临床培养确定的耐碳青霉烯类肺炎克雷伯菌定植患者。近期手术和患者严重程度与 CRKP 的获得独立相关。